Landscapes / Companies
Jiangsu Alphamab Biopharmaceuticals Co., Ltd not checked
FollowEvery new trial, moved date and filing, and a Monday email
Furthest along
4 in Phase 3
4 in Phase 1
Drugs
8
in active trials · 12 in all
Trials
17 active
36 since 2021
Drugs8
| Drug | How it works | Partner | Stage
Sources: FDA: the drug development process, ClinicalTrials.gov glossary | Next date
| Details |
|---|---|---|---|---|---|
— |
Shanghai JMT-Bio |
Phase 3 | 16 Dec 2026soonPhase 3 trial completes | ||
| Next date | 16 Dec 2026 · Phase 3 trial completes | ||||
| Also tested for | HER2-positive Gastric Cancer, Stomach Cancer and 3 more | ||||
| Open drug page | |||||
— |
Alphamab · JMT-Bio |
Phase 3 | 30 Dec 2026Phase 3 trial completes | ||
| Next date | 30 Dec 2026 · Phase 3 trial completes | ||||
| Also tested for | Advanced Solid Tumor, Breast Cancer and 4 more | ||||
| Open drug page | |||||
— |
Phase 3 | 31 Dec 2026Phase 1/2 trial completes | |||
| Next date | 31 Dec 2026 · Phase 1/2 trial completes | ||||
| Also tested for | Advanced Malignant Tumors, Non Small Cell Lung Cancer (NSCLC) and 2 more | ||||
| Open drug page | |||||
— |
Phase 3 | 30 Jun 2027Phase 2 trial completes | |||
| Next date | 30 Jun 2027 · Phase 2 trial completes | ||||
| Also tested for | Advanced Non-small Cell Lung Cancer, Advanced Malignant Solid Tumor and 5 more | ||||
| Open drug page | |||||
— |
Phase 1 | 31 Aug 2027Phase 1 trial completes | |||
| Next date | 31 Aug 2027 · Phase 1 trial completes | ||||
| Also tested for | Advanced Malignant Solid Tumors | ||||
| Open drug page | |||||
— |
Phase 1 | 1 Jul 2028Phase 1 trial completes | |||
| Next date | 1 Jul 2028 · Phase 1 trial completes | ||||
| Also tested for | Advanced Solid Tumor Malignancies | ||||
| Open drug page | |||||
— |
Phase 1 | 31 Oct 2028Phase 1 trial completes | |||
| Next date | 31 Oct 2028 · Phase 1 trial completes | ||||
| Also tested for | Advanced Malignant Solid Tumors | ||||
| Open drug page | |||||
— |
Phase 1 | 30 Dec 2028Phase 1 trial completes | |||
| Next date | 30 Dec 2028 · Phase 1 trial completes | ||||
| Also tested for | Advanced Malignant Solid Tumor | ||||
| Open drug page | |||||
About
- No active trial
- KN019, KN046, KN052, Ningetinib
- SEC filings
- None: it does not file with the US SEC
- Sources
- ClinicalTrials.gov updated 18 Nov 2026 Industry-sponsored drug trials since 2021